13/09/2017 18:05:41

RxS moves to new location to accommodate rapid growth

MANALAPAN, NJ, Sept. 13, 2017 (GLOBE NEWSWIRE) -- RxS LLC (“RxS”), a privately held company providing multi-channel sample management solutions to pharmaceutical and biotech companies, announced today its move to a new location to accommodate the company’s continued growth and success. Remaining in Manalapan, NJ, RxS is now operating at:

195 Route 9 S., Suite 208

Manalapan, NJ 07726

Pharmaceutical and biotech companies are often burdened by the regulations surrounding sample management, and that’s where RxS comes in. RxS offers customizable solutions for multi-channel sample management to companies of all sizes, ensuring compliance, state-of-the-art reporting, and outstanding customer service. “We are a service organization enabled by technology,” says Mark Jara, Principal, Managing Director. “Because RxS has proven to be a valuable business partner for so many companies, RxS has moved to a new location to accommodate our growth and success.”

RxS has maintained organizational growth year after year, including sales, clients, employees, and services.  Over the past two years they had a surge in new clients and business expansion. The new office space will support RxS’s promising trajectory as well as creating a high tech collaborative environment to optimize customer service and enhance technical development.

The move, however, is just one of several new developments for RxS. Concurrent to this action, the company is continuing the growth of its European footprint. In addition, RxS has entered the planning phase for a proposed satellite location in southeastern Florida slated to open by mid-2018.

RxS has become a leading provider of multi-channel sample management solutions. RxS’s growing presence and continued success is credited to its leadership team that collectively has more than 75 years of pharmaceutical expertise, along with the employees’ immense knowledge and understanding of the pharma and biotech industries. Beyond that, RxS has been built on technology and is committed to providing superior customer service.

By having technology at its core, RxS can provide offerings that ensure Prescription Drug Marketing Act compliance and also supply valuable reporting and analytics data. Customers can access up-to-date reporting and analytics data 24 hours a day, seven days a week, a feature that makes proactive monitoring possible. This results in customers having the tools to advance marketing reach and optimizing sample effectiveness.

Customer service is paramount to the team at RxS. In the client-supplier relationship, the company views itself as a business partner rather than simply a vendor as account representatives learn each client’s needs and provide client centric solutions designed to drive success. RxS has found this to be a most effective approach, as the solutions they provide clients are transparent and value-centric in terms of pricing.

RxS’s success is a direct reflection of the value it has provided and continues to provide its customers. For example, by applying industry experiences and a consultative approach, RxS was able to provide a small-sized client with guidance on best practices, lead-in project management and technical integrations during their first prescription representative product sampling launch. The result was an overwhelming success that relieved the client of startup complexities while achieving compliance through a solid forward thinking framework, on time and on budget.

The value RxS provides customers extends also to more established pharmaceutical and biotech companies. For instance, a client needed to transition from having multiple vendors to a consolidated solution, so RxS provided such a solution and also strategic value during the transition. RxS achieved this by working with numerous internal and external stakeholders to identify scope and requirements. The outcome was a solution that met the deadline and budget and also had a positive impact throughout the company, from headquarters to customers.

RxS works with companies of all sizes and provides truly client centric solutions that meet each client’s needs. To learn more about RxS offerings please visit rxsinfo.com. To schedule a visit to their new headquarters, please email sales@rxsinfo.com.

About RxS LLC

RxS LLC, a privately held company in Manalapan, New Jersey, is the leading provider of multi-channel sample management solutions for pharmaceutical and biotech companies. Supported by more than   75 years of combined pharmaceutical leadership experience, RxS has been partnering with pharmaceutical and biotech companies since its founding in 2011 to provide regulatory compliance in order to lessen the administrative burden of the Prescription Drug Marketing Act. RxS offerings go beyond regulatory compliance, providing solutions to increase marketing and sample effectiveness. Driven by technology, RxS offers a suite of proprietary services and software solutions to ensure regulatory compliance and maximize analytics data.

# # #

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/3fa66210-a0be-4307-b66f-3fc3e92e4361

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/2c04c05e-388c-4cc6-a173-cef94eb39845

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/47e38a37-f9b1-41d3-883a-9ba03c746912

Drew Deeter

RxS

2153483890

drew@deeterusa.com

RxS moved to new office at 195 Route 9 S., Suite 208, Manalapan, NJ 07726

Interior photo of new RxS home office building.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
18 Sep
FING-B
Goodwrench, sikke en omgang vrøvl.   Det er ikke kun hyklerisk, men også dybt patetisk, når du komme..
36
21 Sep
BAVA
Nogle gange...bare nogle gange ville jeg godt nok vaere glad og taknemmelig hvis vi ikke evig og alt..
25
19 Sep
PNDORA
Her er min model ;)      
23
21 Sep
I:SP500
Hej   Der er lige nu kommet nye tal fra Conference Board omkring de ledende indikatorer. Vores konju..
21
24 Sep
 
De fleste danskere, svenskere og tyskere er ikke racister. Men at se sit land blive invaderet af mus..
17
20 Sep
SAS-DKK
Norwegian har gjort det flot, og konkurrence kan være godt det "kan" højne kvaliteten i nogen tilfæl..
17
18 Sep
FING-B
Goodwrench, har du da hørt en loppe gø. Det er dybt imponerende, hvordan du igen og igen udstiller d..
16
20 Sep
PNDORA
Donlupo - Fik du skrevet fra den forkerte profil?
15
23 Sep
OMXC25
Kun 3,4 på Richerskalaen. Det er nok bare Fedekim, der har vendt sig i sengen.
14
23 Sep
 
Jeg har nedskrevet min strategi efter, at jeg er blevet træt af dumme indkøb med for magt EI skramme..
13

Alliance Trust PLC : Net Asset Value(s)

25/09/2017 13:10:52
ALLIANCE TRUST PLC                                    At the close of business on Friday 22 September 2017: The Company's NAV per ordinary share, valued on a bid price basis with Debt at Par, was -       excluding income, 748.1p -       including income, 756.0p  The Company's NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was -       excluding in..

Form 8.5 (EPT/RI) - Booker Group plc

25/09/2017 08:07:28
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY 1.         KEY INFORMATION (a) Name of exempt principal trader:   Investec Bank plc   (b) Name of offeror/offeree in relation to whose relevant se..

Alliance Trust PLC : Transaction in Own Shares

25/09/2017 07:39:49
25 September 2017  Alliance Trust PLC TRANSACTION IN OWN SHARES  The Board of Alliance Trust PLC ("the Company") announces that on 22 September 2017 the Company purchased for cancellation 54,330 ordinary shares of 2.5p each at a price of 704.6964p per share.  Therefore, the total number of voting rights in the Company is now 349,635,321.    The above figure (349,635,321) may be used by sh..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Gigya, the Market Leader in Customer Identity and Access Management, to be Acquired by SAP
2
iLOOKABOUT Launches New Mobile Appraiser Product at IAAO Conference
3
Aerojet Rocketdyne Supports ULA Launch of Classified Satellite for the U.S. Government
4
OCEANTEAM ASA - Dutch Jos van Dijk appointed Group Chief Financial Officer (CFO)
5
Thinfilm Launches NFC Scanner App for iPhones as Apple Extends NFC Functionality Beyond Payments with Release of iOS 11

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
25 September 2017 14:20:20
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20170921.1 - EUROWEB3 - 2017-09-25 15:20:20 - 2017-09-25 14:20:20 - 1000 - Website: OKAY